☰

Walter A. Scott - Publications

Affiliations: 
University of Miami, Coral Gables, FL 
Area:
Biochemistry, Microbiology Biology
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Árquez MA, Martín-Alonso S, Gorelick RJ, Scott WA, Acosta-Hoyos AJ, Menéndez-Arias L. Nucleocapsid protein precursors NCp9 and NCp15 suppress ATP-mediated rescue of AZT-terminated primers by HIV-1 reverse transcriptase. Antimicrobial Agents and Chemotherapy. PMID 32747359 DOI: 10.1128/Aac.00958-20  0.478
2013 Lu G, Matsuura SE, Barrientos A, Scott WA. HIV-1 infection is blocked at an early stage in cells devoid of mitochondrial DNA. Plos One. 8: e78035. PMID 24205077 DOI: 10.1371/Journal.Pone.0078035  0.437
2012 Acosta-Hoyos AJ, Matsuura SE, Meyer PR, Scott WA. A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation. Journal of Virology. 86: 5122-33. PMID 22379084 DOI: 10.1128/Jvi.05767-11  0.392
2011 Scott WA. Structures of reverse transcriptase pre- and post-excision complexes shed new light on HIV-1 AZT resistance. Viruses. 3: 20-5. PMID 21980583 DOI: 10.3390/V3010020  0.467
2010 Acosta-Hoyos AJ, Scott WA. The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance. Viruses. 2: 372-394. PMID 20523911 DOI: 10.3390/V2020372  0.475
2008 Rutvisuttinunt W, Meyer PR, Scott WA. Interactions between HIV-1 reverse transcriptase and the downstream template strand in stable complexes with primer-template. Plos One. 3: e3561. PMID 18974785 DOI: 10.1371/Journal.Pone.0003561  0.649
2007 Meyer PR, Rutvisuttinunt W, Matsuura SE, So AG, Scott WA. Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet. Journal of Molecular Biology. 369: 41-54. PMID 17400246 DOI: 10.1016/J.Jmb.2007.03.006  0.661
2006 Meyer PR, Smith AJ, Matsuura SE, Scott WA. Chain-terminating dinucleoside tetraphosphates are substrates for DNA polymerization by human immunodeficiency virus type 1 reverse transcriptase with increased activity against thymidine analogue-resistant mutants. Antimicrobial Agents and Chemotherapy. 50: 3607-14. PMID 16940076 DOI: 10.1128/Aac.00537-06  0.442
2006 Smith AJ, Scott WA. The influence of natural substrates and inhibitors on the nucleotide-dependent excision activity of HIV-1 reverse transcriptase in the infected cell. Current Pharmaceutical Design. 12: 1827-41. PMID 16724950 DOI: 10.2174/138161206776873572  0.429
2005 Smith AJ, Meyer PR, Asthana D, Ashman MR, Scott WA. Intracellular substrates for the primer-unblocking reaction by human immunodeficiency virus type 1 reverse transcriptase: detection and quantitation in extracts from quiescent- and activated-lymphocyte subpopulations. Antimicrobial Agents and Chemotherapy. 49: 1761-9. PMID 15855493 DOI: 10.1128/Aac.49.5.1761-1769.2005  0.426
2004 Lorenzo E, Colon MC, Almodovar S, Maldonado IM, Gonzalez S, Costa SE, Hill MD, Mendoza R, Sepulveda G, Yanagihara R, Nerurkar V, Kumar R, Yamamura Y, Scott WA, Kumar A. Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART. Virology. 330: 116-26. PMID 15527839 DOI: 10.1016/J.Virol.2004.09.015  0.332
2004 Meyer PR, Smith AJ, Matsuura SE, Scott WA. Effects of primer-template sequence on ATP-dependent removal of chain-terminating nucleotide analogues by HIV-1 reverse transcriptase. The Journal of Biological Chemistry. 279: 45389-98. PMID 15308646 DOI: 10.1074/Jbc.M405072200  0.412
2003 Meyer PR, Matsuura SE, Zonarich D, Chopra RR, Pendarvis E, Bazmi HZ, Mellors JW, Scott WA. Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase. Journal of Virology. 77: 6127-37. PMID 12743270 DOI: 10.1128/Jvi.77.11.6127-6137.2003  0.462
2003 Subramanian K, Rutvisuttinunt W, Scott W, Myers RS. The enzymatic basis of processivity in lambda exonuclease. Nucleic Acids Research. 31: 1585-96. PMID 12626699 DOI: 10.1093/Nar/Gkg266  0.611
2003 Meyer PR, Lennerstrand J, Matsuura SE, Larder BA, Scott WA. Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation. Journal of Virology. 77: 3871-7. PMID 12610164 DOI: 10.1128/Jvi.77.6.3871-3877.2003  0.408
2002 Meyer PR, Matsuura SE, Tolun AA, Pfeifer I, So AG, Mellors JW, Scott WA. Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase. Antimicrobial Agents and Chemotherapy. 46: 1540-5. PMID 11959594 DOI: 10.1128/Aac.46.5.1540-1545.2002  0.383
2001 Scott WA. The enzymatic basis for thymidine analogue resistance in HIV-1 Aids Reviews. 3: 194-200.  0.338
2000 Meyer PR, Matsuura SE, Schinazi RF, So AG, Scott WA. Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates. Antimicrobial Agents and Chemotherapy. 44: 3465-72. PMID 11083661 DOI: 10.1128/Aac.44.12.3465-3472.2000  0.458
1999 Meyer PR, Matsuura SE, Mian AM, So AG, Scott WA. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Molecular Cell. 4: 35-43. PMID 10445025 DOI: 10.1016/S1097-2765(00)80185-9  0.421
1998 Meyer PR, Matsuura SE, So AG, Scott WA. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proceedings of the National Academy of Sciences of the United States of America. 95: 13471-6. PMID 9811824 DOI: 10.1073/Pnas.95.23.13471  0.482
1998 Fiscus SA, Hughes MD, Lathey JL, Pi T, Jackson B, Rasheed S, Elbeik T, Reichman R, Japour A, Byington R, Scott W, Griffith BP, Katzenstein DA, Hammer SM. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team. The Journal of Infectious Diseases. 177: 625-33. PMID 9498441 DOI: 10.1086/514248  0.376
1998 Lathey JL, Hughes MD, Fiscus SA, Pi T, Jackson JB, Rasheed S, Elbeik T, Reichman R, Japour A, D'Aquila RT, Scott W, Griffith BP, Hammer SM, Katzenstein DA. Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. The Journal of Infectious Diseases. 177: 617-24. PMID 9498440 DOI: 10.1086/514250  0.409
1997 Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Annals of Internal Medicine. 126: 929-38. PMID 9182469 DOI: 10.7326/0003-4819-126-12-199706150-00001  0.364
1997 Tong W, Lu CD, Sharma SK, Matsuura S, So AG, Scott WA. Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase. Biochemistry. 36: 5749-57. PMID 9153415 DOI: 10.1021/Bi962410Z  0.5
1996 Scott WA, Brambilla D, Siwak E, Beatty C, Bremer J, Coombs RW, Farzadegan H, Fiscus SA, Hammer SM, Hollinger FB, Khan N, Rasheed S, Reichelderfer PS. Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group. Journal of Clinical Microbiology. 34: 2312-5. PMID 8862609 DOI: 10.1128/Jcm.34.9.2312-2315.1996  0.301
1996 Ünal A, Lorenzo E, Brown M, Smith L, Matsuura S, Scott G, Scott W. Reverse transcriptase mutations in HIV-1-infected children treated with zidovudine. Journal of Acquired Immune Deficiency Syndromes. 13: 140-145. PMID 8862278 DOI: 10.1097/00042560-199610010-00004  0.352
1996 Hutto C, Zhou Y, He J, Geffin R, Hill M, Scott W, Wood C. Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. Journal of Virology. 70: 3589-98. PMID 8648693 DOI: 10.1128/Jvi.70.6.3589-3598.1996  0.358
1994 Zhan X, Tan CK, Scott WA, Mian AM, Downey KM, So AG. Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide. Biochemistry. 33: 1366-72. PMID 7508746 DOI: 10.1021/Bi00172A012  0.325
1988 Brown ME, Amin J, Schiller P, Voellmy R, Scott WA. Determinants for the DNase I-hypersensitive chromatin structure 5' to a human HSP70 gene. Journal of Molecular Biology. 203: 107-17. PMID 3184184 DOI: 10.1016/0022-2836(88)90095-2  0.3
1985 Scott WA. Torsional stress in eukaryotic chromatin Bioessays. 2: 34-36. DOI: 10.1002/Bies.950020110  0.32
1980 Wigmore DJ, Eaton RW, Scott WA. Endonuclease-sensitive regions in SV40 chromatin from cells infected with duplicated mutants. Virology. 104: 462-73. PMID 6249038 DOI: 10.1016/0042-6822(80)90348-7  0.305
1978 Scott WA, Wigmore DJ. Sites in simian virus 40 chromatin which are preferentially cleaved by endonucleases. Cell. 15: 1511-8. PMID 215331 DOI: 10.1016/0092-8674(78)90073-9  0.349
Show low-probability matches.